MktsMarkets

Ironwood Pharmaceuticals, Inc.
NASDAQ: IRWDKey statistics
IRWD News
Stories mentioning IRWD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 106,506 | 47,709 | 122,060 | 85,239 | 41,143 | 90,545 | 91,592 | 94,396 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 21,940 | 21,863 | 22,468 | 23,373 | 27,432 | 25,391 | 29,827 | 30,388 |
| Sales General & Admin | 12,033 | 19,293 | 21,908 | 16,795 | 24,260 | 33,590 | 36,113 | 36,964 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 72,573 | 6,805 | 75,484 | 45,321 | (29,108) | 31,491 | 25,636 | 24,977 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 42.00 | 77.00 | 40.00 | 39.00 | 37.00 | |||
| Pretax Income | 65,172 | 455.00 | 68,020 | 37,822 | (36,272) | 23,995 | 17,369 | 18,876 |
| Tax Provision | 24,399 | 2,731 | 27,940 | 14,223 | 1,114 | 21,739 | 13,723 | 19,736 |
| Net Income (Loss) | 40,773 | (2,276) | 40,080 | 23,599 | (37,386) | 2,256 | 3,646 | (860.00) |
| Earnings Per Share (Basic) | 0.25 | (0.01) | 0.25 | 0.15 | (0.23) | 0.01 | 0.02 | (0.01) |
| Earnings Per Share (Diluted) | 0.24 | (0.01) | 0.23 | 0.14 | (0.23) | 0.01 | 0.02 | (0.01) |
| Weighted Average Shares Outstanding (Basic) | 163,451 | 161,842 | 162,215 | 161,723 | 160,974 | 159,083 | 159,706 | 159,014 |
| Weighted Average Shares Outstanding (Diluted) | 166,690 | 162,983 | 177,764 | 176,837 | 160,974 | 160,084 | 160,232 | 159,014 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IRWD
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is a stock listed on the Nasdaq Stock Market under the ticker symbol IRWD. It last traded at $4.70 (Nov 20, 2026, 4:00 PM ET), down 0.2% on the day. That gives Ironwood Pharmaceuticals a market capitalisation of $779.7M and a price-to-earnings ratio of 6.0.
Over the past 52 weeks IRWD has traded between $2.95 and $5.78.
Revenue for the quarter ended Mar 31, 2026 was $106.5M; net income $40.8M. Revenue was up 159% from $41.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $106.5M | $40.8M | 38.3% |
| Dec 31, 2025 | $47.7M | -$2.3M | -4.8% |
| Sep 30, 2025 | $122.1M | $40.1M | 32.8% |
| Jun 30, 2025 | $85.2M | $23.6M | 27.7% |
From Ironwood Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…